Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Antioxidants (Basel, Switzerland)|August 27, 2021
A Novel Immunoassay for Malondialdehyde-Conjugated Low-Density Lipoprotein Measures Dynamic Changes in the Blood of Patients Undergoing Coronary Artery Bypass Graft SurgerySamata S Pandey, Adam Hartley, Mikhail Caga-Anan, et al.The Laryngoscope|December 13, 2023
Current Practices in Voice Data Collection and Limitations to Voice AI Research: A National SurveyEmily Evangelista, Rohan Kale, Desiree McCutcheon, et al.ACS Medicinal Chemistry Letters|January 19, 2023
Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 AgonistJian Zhao, Shimiao Wang, Stacy Markison, et al.Bioorganic & Medicinal Chemistry Letters|September 8, 2007
Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptorWanlong Jiang, Fabio C Tucci, Joe A Tran, et al.Hybridoma (2005)|April 19, 2012
Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoproteinShang-Hung Chang, Michael Johns, Joseph J Boyle, et al.Journal of Medicinal Chemistry|October 9, 2007
Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexiaChen Chen, Wanlong Jiang, Fabio Tucci, et al.Journal of Medicinal Chemistry|October 29, 2008
Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic painBrian Dyck, Junko Tamiya, Florence Jovic, et al.Bioorganic & Medicinal Chemistry Letters|May 23, 2022
Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinismJian Zhao, Shimiao Wang, Sun Hee Kim, et al.Bioorganic & Medicinal Chemistry|April 18, 2008
Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonistsChen Chen, Fabio C Tucci, Wanlong Jiang, et al.Blood|October 9, 2014
PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expressionM Bilal Iqbal, Michael Johns, Jun Cao, et al.Pageof 8